Nature Publishes Overview of COVID-19 Vaccine R & D

Sept. 9, 2020

On Friday (Sept. 4), Nature published a paper, “Evolution of the COVID-19 vaccine development landscape,” which provides extensive data about COVID-19 vaccine research and development and input on what should be expected from COVID-19 vaccine development and what to look for in upcoming vaccine data.

The researchers who compiled the data indicate that as of Sept. 2, 321 vaccine candidates are in development, compared to 112 in April. Of those, 32 vaccine candidates are in clinical trials and will enroll more than 280,000 participants from 470 sites in 34 different countries. The most advanced clinical candidates are now in phase III trials, and data to support licensure are anticipated to be available later this year.